Strategy Inc: Jarrod M. Patten sells 2,750 shares
A Strategy Inc (MSTR) director reported five Class A share sales at $150.5400, $152.0000, $154.4700, $156.0000 and $158.0000 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Strategy Inc (MSTR) director Jarrod M. Patten exercised options for 1,400 Class A shares on October 8, 2026, and 1,350 shares on October 9, 2026, at an exercise price of $18.2360 per share. He reported sales totaling 2,750 shares: 950 at $150.5400 and 450 at $152.0000 on October 8; on October 9, 450 shares each at $154.4700, $156.0000, and $158.0000. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Director Stock Option (Right to buy) F2 | 1,350 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 1,350 | $18.236 | $25K |
| Sale | Class A Common Stock | 450 | $154.47 | $70K |
| Sale | Class A Common Stock | 450 | $156.00 | $70K |
| Sale | Class A Common Stock | 450 | $158.00 | $71K |
| Exercise | Director Stock Option (Right to buy) F1 | 1,400 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 1,400 | $18.236 | $26K |
| Sale | Class A Common Stock | 950 | $150.54 | $143K |
| Sale | Class A Common Stock | 450 | $152.00 | $68K |
| holding | Series A Perpetual Strife Preferred Stock | -- | -- | -- |
| holding | Series A Perpetual Stretch Preferred Stock | -- | -- | -- |
| holding | Series A Perpetual Stride Preferred Stock | -- | -- | -- |
Footnotes (2)
- F1. The 1,400 shares exercised on October 8, 2026 pursuant to this option vested on May 31, 2020. Of the remaining 23,450 shares pursuant to this option, 10,950 vested on May 31, 2020, and 12,500 shares vested on May 31, 2021.
- F2. The 1,350 shares exercised on October 9, 2026 pursuant to this option vested on May 31, 2020. Of the remaining 22,100 shares pursuant to this option, 9,600 vested on May 31, 2020, and 12,500 shares vested on May 31, 2021.
Key Figures
Key Terms
Director Stock Option (Right to buy) technical
exercise price financial
vested financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many MSTR options did Jarrod M. Patten exercise?
AI-generated analysis. How Rhea-AI works. Not financial advice.